A standard controlled clinical study on Virechana Karma and Lekhana Basti in the management of dyslipidemia (Medoroga)
Journal name: AYU (Journal of Research in Ayurveda)
Original article title: A standard controlled clinical study on Virechana Karma and Lekhana Basti in the management of dyslipidemia (Medoroga)
AYU is an internationally recognized quarterly journal dedicated to advancing research in Ayurveda. The journal covers a wide range of topics, including clinical and pharmacological research in Ayurveda's eight branches, herbal remedies, phytochemistry, and ethnomedicine.
Original source:
This page is merely a summary which is automatically generated hence you should visit the source to read the original article which includes the author, publication date, notes and references.
B.A Pooja
Santosh Kumar Bhatted
AYU (Journal of Research in Ayurveda):
(An International Quarterly Journal of Research in Ayurveda)
Full text available for: A standard controlled clinical study on Virechana Karma and Lekhana Basti in the management of dyslipidemia (Medoroga)
Year: 2016 | Doi: 10.4103/ayu.AYU_14_15
Copyright (license): CC BY-NC-SA 4.0
Download the PDF file of the original publication
Summary of article contents:
Background: Dyslipidemia, a major risk factor of coronary heart disease, is the leading single cause of death in the world. Currently available hypolipidemic agents have been associated with a large number of side effects. The radical Ayurveda Samshodhana Chikitsa as a treatment protocol can provide better effect. Therefore, the present study was designed to evaluate the effect of Virechana Karma and Lekhana Basti in dyslipidemia.
Other Science Concepts:
Discover the significance of concepts within the article: ‘A standard controlled clinical study on Virechana Karma and Lekhana Basti in the management of dyslipidemia (Medoroga)’. Further sources in the context of Science might help you critically compare this page with similair documents:
Medoroga, Bastikarman, Vatadosha, Pittadosha, Medodhatu, Adverse effect, Randomized controlled trial, Virechana Karma, Ethical committee, National Institute of Ayurveda, Dyslipidemia, Lipid profile, High-density lipoprotein, Low-density lipoprotein, Lekhana Basti, Coronary heart disease, Triglycerides level, Atorvastatin, Agni Vaishamya, Myopathy, Renal failure.